Why the Oncolytic Virotherapy Summit?
The 5th OV Summit is the fastest route to in-depth discussions with organizations prioritizing oncolytic virus drug development. OV provides an unrivalled opportunity for your brand, your message and your reputation to be showcased in front of the leading minds of the growing ‘Oncology Virus Industry’.
Who do I get to meet?
Gathering stakeholders and key opinion leaders, OV is the ultimate opportunity to position yourself as an expert in front of 100+ drug developers. Elevate your company’s standing and influence the future of oncolytic virus drug development.
What can OV do for you?
Boost your brand; Engage industry decision makers; Demonstrate thought leadership
We understand each business is different so we’ll work with you to build a bespoke partnership opportunity to fulfil your 2019/2020 business objectives.
Previous partners have benefitted from:
- Panel participation
- Dedicated presentations
- Leading roundtable discussions
- Tailored branding
How is OV different?
At this year’s Oncolytic Virotherapy Summit, you can expect:
- A HIGHER CALIBRE OF CONVERSATIONS: with over 10 hours of networking you’ll have more opportunities than ever for significant discussions with your key prospects
- DEDICATED ICEBREAKER SESSIONS FROM THE START: starting a conversation is never easy, so let us start them for you
- INTERACTIVE SESSIONS AS STANDARD: engage your audience in solution focused exchanges at this year’s panel discussions, speed learning roundtables and poster session
Maximise your return on investment at the only conference to bring together industry and leaders to further the development of Oncolytic Virotherapies.